Skip to main content

GILEAD SCIENCES, INC.

Location
FOSTER CITY, CA
Portfolio Value
Mid $1,457,933,692
Diversification
Highly concentrated
Reports for
Gilead Therapeutics A1 Unlimited Co
Filing Date
Global Rank
#1,912 / 8,728 ▼ 82
Top Industry
Biotechnology 100.0%
3Y Alpha vs SPY
+8.7%
Period ended 51 days ago
Filed Nov 6, 2026 · 14d
8 quarters · since Dec 2024

Regulatory profile

From Form ADV, the SEC filer profile, 13D/13G type codes and N-CEN, never from the name.

Holder type
Unknown
SIC code
2836

Schedule 13D/13G stakes

Stakes of 5% or more disclosed on Schedule 13D or 13G, each on the filer's latest filing for the security. These are event-dated stakes, not the quarter-end 13F portfolio below.

Company Schedule Filed Shares % of class Status
RCUS Arcus Biosciences, Inc. 13D/A Passive investment 4mo 31,424,760 24.7% Current
ASMB Assembly Biosciences, Inc. 13D/A not restated by this amendment, the earlier 13D's purpose stands 6mo 4,977,089 25.1% Current
XLO Xilio Therapeutics, Inc. 13G/A 9mo 1,036,977 19.9% Current
LKFT Lakefront Biotherapeutics NV 13D/A Strategic alternatives 1y 20,981,010 29.9% Current
KYTX Kyverna Therapeutics, Inc. 13G 2y 4,126,119 9.6% Unconfirmed since Feb 12, 2024

A 13D or 13G stays in force until its filer amends it and no amendment is due without a material change, so a stake with no filing in 24 months reads unconfirmed, never sold. An amendment reporting under 5% ends the filer's duty to amend, not necessarily the holding. Shares are restated onto today's split basis. Show 6 exited, below-5% or retired stakes

Portfolio style

Measured from the filed 13F common-share book for Sep 30, 2026, never from the firm's own description.

Style
Concentrated
The top 10 positions are 100.0% of the book (60%+)
Turnover
Low turnover
0.7% over the last four quarters (under 30%)
Horizon
Medium horizon
Value-weighted holding period 8.0 quarters (4 to under 12)

Closest benchmark: the S&P SmallCap 600 as of 2026-09-30, active share 99.9%; sector active share 90.5% against the combined 13F book's sector weights.

Over time 8 measured quarters

How the bands are measured

Style bands measure the filed 13F common-share book each closed quarter, tested in this order. Unknown: under $10,000,000 of valued equity or 5 stocks. Index-like (100+ stocks): active share of 20% or less against the closest benchmark, which is the S&P 500, S&P MidCap 400, S&P SmallCap 600, Russell 1000, Russell 2000, Nasdaq-100 or Dow Jones Industrial Average (weighted by an index-tracking fund's reported holdings or the index's constituents nearest the quarter end, over the names resolved to companies, and only when those are 90%+ of its weight) or every 13F filer's combined book, or index series holding 80%+ of the registered fund assets it advises (N-CEN) and equal to 50%+ of its book. Systematic-like: 500+ stocks, 100%+ annual turnover and a top 10 weight of 25% or less. Concentrated: a top 10 weight of 60%+ or 12 or fewer effective positions. Diversified active: none of these. Turnover is the smaller of buys and sells over average equity value, summed over four quarters: low under 30%, high 100%+. Horizon is the value-weighted number of quarters each position has been held: short under 4, long 12+. Stocks and the top 10 weight count issuers: share classes of one company are one stock, and options are left out, so they can differ from the position count and top 10 concentration of GetInstitutionSummary and GetInstitutionPortfolio, which count each listed share class.

Clone Performance

Build a hypothetical price-return history from this filer's public 13F holdings.

View clone backtest

Portfolio Concentration

5 common stock positions · as of Sep 30, 2026 · Δ vs Jun 30, 2026
Top Position
55.7%
−3.1 pts
Top 5
100.0%
0.0 pts
Top 10
100.0%
0.0 pts
HHI
4,322
Dec 2024 → Sep 2026 · range 2,616 – 4,446
Highly concentrated−123

Portfolio Trend

8 quarters · across all stocks

Sector Breakdown

Common stock positions · as of Sep 30, 2026
Sector % Portfolio Value
Healthcare 100.0% $1,457,933,692

Last Quarter's Activity

Export CSV
Sep 30, 2026 vs Jun 30, 2026

Added To

Positions the filer increased
No qualifying positions this quarter.

Trimmed

Positions the filer reduced
No qualifying positions this quarter.

New Positions

Positions the filer opened this quarter
No qualifying positions this quarter.

Sold Out

Positions the filer fully exited
No qualifying positions this quarter.

Portfolio Positions

Export CSV View 13F filing
5 tracked positions · $1,457,933,692 total · filing declares 5 positions · $1,463,841,605 · as of Sep 30, 2026
Ticker Company Shares Value (USD) % of Portfolio History

Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.